Statins linked with idiopathic inflammatory myositis

Patients with the muscle disease nearly twice as likely to have been on the cholesterol-lowering medication

Patients with the rare muscle disease, idiopathic inflammatory myositis, are nearly twice as likely to have been on statin therapy than matched population controls, an Australian study shows.


Using data from 1990-2014 from the SA myositis database, 221 patients older than 40 and diagnosed with histologically confirmed idiopathic inflammatory myositis were compared with 662 matched controls from a general population state database. 

Compared with controls without the disorder, patients with myositis had a 79% increased likelihood